Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-01-14
1986-01-28
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514345, 546122, 546123, 546283, 546284, A61K 31435, C07D47104, C07D21324
Patent
active
045671869
ABSTRACT:
3-Z-5-Q-1,6-naphthyridin-2(1H)-ones (I) or salts thereof, where Z is hydrogen or cyano, and Q is 2(or 3)-furanyl, 2(or 3)-thienyl, 4(or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two methyl substituents, are useful as cardiotonic agents and corresponding compounds where Z is carboxy are useful as intermediates. Also shown as intermediates are 5-(Q-CO)-6-[2-(di-lower-alkylamino)ethenyl]-2(1H)-pyridinones (II) or salts thereof, where Q is defined as above. Processes for preparing said compounds (I and II) are shown.
REFERENCES:
patent: 4412077 (1983-10-01), Lesher et al.
patent: 4415580 (1983-11-01), Lesher et al.
Hawes and Gorecki, J. Med. Chem. 16, 849-853 (1973).
U.S. patent application Ser. No. 630,810, filed Jul. 13, 1984 (Lesher and Singh).
Lesher George Y.
Singh Baldev
Bair Robert K.
Cassatt Barbara
DuPont Paul E.
Jiles Henry R.
Sterling Drug Inc.
LandOfFree
5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1306474